SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Holdings Inc

Ondas Holdings is trending amid reports that its subsidiary, Airobotics, has been selected as the prime contractor for Israel's border security project, further fueled by broader discussions around increased defense spending. The community is highly bullish, viewing Ondas as a significant player in the evolving autonomous drone and counter-drone technology sector. This confluence of news positions the company as a leader in a burgeoning defense super cycle, driving strong investor enthusiasm.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies (OPEN) is trending due to overwhelming bullish sentiment following news of significant government initiatives aimed at lowering mortgage rates. The community is actively discussing the potential for a massive short squeeze, drawing parallels to past explosive growth stocks, as expectations rise for a booming real estate market. This enthusiasm is driving conversations around OPEN's future, despite some underlying concerns about its business model and warrant-related dilution.

Polygon

Polygon (POL) is trending amidst community discussions regarding a potential return to its former MATIC ticker, a move aimed at leveraging strong brand familiarity and addressing user confusion. This debate, coupled with ongoing accumulation from large holders and its foundational role as a leading Layer 2 solution for Ethereum, drives a generally bullish sentiment among the community.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is capturing significant attention following recent industry developments, notably Marvell's acquisition of a key partner and Nvidia's increased emphasis on photonics for advanced AI infrastructure. The community is actively discussing POET's unique optical interposer platform, which promises disruptive advancements in speed, cost, and power efficiency for next-generation data centers, fueling high anticipation for forthcoming commercialization milestones and strategic orders.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is navigating significant investor conversation following a recent analyst downgrade and market concerns regarding intensifying competition in the GLP-1 weight loss sector, particularly with the rise of oral treatment options. While some in the community express frustration over recent price action and perceived fundamental weaknesses, many bulls are actively accumulating, pointing to strong underlying revenue growth, international expansion, and high short interest as catalysts for a potential rebound, especially with anticipated marketing pushes for its Labs segment.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as digital video compact disc player, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

Taiwan Semiconductor is experiencing heightened discussion driven by recent strong sales figures and a significant analyst upgrade underscoring its multi-year AI growth potential. Investors are actively debating its essential role in the advanced chip supply chain, balancing robust demand for AI chips with persistent geopolitical tensions surrounding Taiwan.

United States Commodity Funds LLC - United States Oil Fund

United States Oil Fund

The United States Oil Fund (USO) is trending due to escalating geopolitical tensions surrounding Venezuela, with significant speculation arising from U.S. actions, including seized oil tankers and military threats. This has ignited intense community debate on potential crude supply disruptions versus the prospect of increased oil flow under U.S. influence, leading to a polarized outlook on oil's near-term direction.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

The controversial ICE agent-involved shooting in Minneapolis is a dominant discussion point for $DJT, with community members sharply divided over the justification of force and characterizing the event as either murder or a necessary act of self-defense. Amidst this, users are also actively debating recent statements from Donald Trump regarding potential housing market interventions, including instructing representatives to consider buying $200 billion in mortgage bonds and restricting institutional homeownership, with some critics drawing comparisons to "democratic socialist" policies.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster is generating significant buzz following its strong earnings report and raised guidance, reinforcing its position as a leader in the evolving physical AI and robotics landscape across numerous applications. The community is actively discussing Ouster's robust financial position, ample cash, and diversified deployments in smart infrastructure, autonomous logistics, and defense, especially as competitor challenges reshape the LiDAR sector.

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health (OSCR) is trending sharply higher as the community actively debates the implications of the House passing a bill to extend Affordable Care Act (ACA) subsidies. Investors are weighing the potential for a significant short squeeze and further upside if the Senate approves the extension, while others remain cautious, citing uncertainty regarding the bill's final legislative fate. A recent analyst upgrade further fuels discussion around Oscar's valuation and its position within the evolving healthcare technology landscape.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Lifecore Biomedical (NASDAQ:LFCR) Stock Rating Upgraded by Zacks Research

Zacks Research raised Lifecore Biomedical to a "hold" rating in a research report on Thursday...

Lifecore Biomedical (LFCR) Projected to Post Quarterly Earnings on Thursday

Lifecore Biomedical (NASDAQ:LFCR) will be releasing its Q2 2026 earnings after the market closes on Thursday, January 1. (View Earnings Report at...

HALPER SADEH LLC ENCOURAGES LIFECORE BIOMEDICAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

HALPER SADEH LLC ENCOURAGES LIFECORE BIOMEDICAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS HALPER SADEH LLC ENCOURAGES LIFECORE BIOMEDICAL, INC. SHAREHOLDERS TO CONTACT THE FIRM...

734,533 Shares in Lifecore Biomedical, Inc. $LFCR Bought by Grizzlyrock Capital LLC

Grizzlyrock Capital LLC purchased a new stake in shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with...

22NW LP Sells 1,490,981 Shares of Lifecore Biomedical, Inc. $LFCR

22NW LP lowered its position in Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) by 84.9% in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned...

Halper Sadeh LLC Encourages Lifecore Biomedical, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Lifecore Biomedical, Inc. (NASDAQ: LFCR) breached their fiduciary duties to shareholders. If...

Q4 Earnings Forecast for LFCR Issued By Barrington Research

Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) - Equities researchers at Barrington Research issued their Q4 2025 earnings per share (EPS) estimates for Lifecore Biomedical in a research...

Lifecore Biomedical (NASDAQ:LFCR) Releases Earnings Results, Beats Estimates By $0.01 EPS

Lifecore Biomedical (NASDAQ:LFCR - Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.29) earnings per share (EPS) for the quarter, beating the consensus...

Lifecore Biomedical (LFCR) Reports Q1 Loss, Beats Revenue Estimates

Lifecore Biomedical (LFCR) delivered earnings and revenue surprises of +3.33% and +16.60%, respectively, for the quarter ended August 2025. Do the numbers hold clues to what lies ahead for the stock?

Harmony Biosciences Holdings, Inc. (HRMY) Q3 Earnings Miss Estimates

Harmony Biosciences (HRMY) delivered earnings and revenue surprises of -5.43% and +4.59%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Lifecore Biomedical, Inc. engages in the development and manufacturing of pharmaceuticals products and services. It focuses on selling products utilizing hyaluronan, a naturally occurring polysaccharide that is widely distributed in the extracellular matrix of connective tissues in both animals and humans, and non-HA products for medical use primarily in the Ophthalmic, Orthopedic and other markets. The company was founded by Otto Sartorius in 1965 and is headquartered in Chaska, MN.

Lifecore Biomedical Inc

Yes — Rates Move Meaningfully Lower

Short-Term Dip, No Lasting Impact

No — Mostly Political Noise

Other – Comment Below

President Trump says he’s directing $200 billion into mortgage bond purchases to bring down rates and improve housing affordability. With questions around execution, authority, and real market impact, do you think this move will actually lower mortgage rates in 2026?

Will Trump’s Mortgage Bond Plan Actually Lower Rates in 2026?

Current Price	$7.77
Prev Close	$7.89
Open	$7.84
Dividend Yield	0.00%
50-Day Moving Average	$7.69
Beta	1.81
Avg. Volume	165,666.05
PE Ratio	-5.96

52-Week High	$8.85
52-Week Low	$4.76
Market Capitalization	$295.61M
EPS (Annual)	-$1.27
Price to Book	-27.63
Revenue Per Employee	$317,406.40
Enterprise Value/EBITDA	N/A

LFCR
Lifecore Biomedical Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest LFCR News

LFCRLifecore Biomedical Inc